Scholarlink

<p>Notochordal cells (NC) have promise as a regenerative therapy for intervertebral disc (IVD) degeneration, but their maintenance in culture remains challenging. The study hypothesis is that nucleus pulposus (NP) cells can undergo reversion to NC-type cells through CRISPR/dCas9 activation of FoxA2. Serial passaging of cells isolated from NP shows loss of FoxA2, Brachyury (T), and Noto expression. Transient FoxA2 overexpression increased the levels of NC biomarkers, keratin, CD24, and SHH in passaged cells. So FoxA2-expressing cells were generated using CRISPR/dCas9-SAM. Analysis showed the presence of some vacuolated cells, elevated NC marker expression of Fox A2, Noto, Brachyury, and keratin and improved in vitro NP tissue formation (determined by quantifying proteoglycan content). TGFβ3 treatment enhanced tissue formation. Injected FoxA2-expressing cells survived and produced NP matrix molecules in an ex vivo bovine IVD injury model. The findings suggest FoxA2-expressing NC-type cells can be generated which may have potential to advance cell-based therapies for disc degeneration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Reversion of passaged nucleus pulposus cells to notochordal-type cells by FoxA2 upregulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月31日

查看全文
  • Sajjad Ashraf,
  • Aaryn Montgomery-Song,
  • Campbell Thom,
  • Evan Davison Kotler,
  • Byron Chan,
  • Alena Zelinka,
  • Paul Santerre,
  • Rita Kandel

摘要

Notochordal cells (NC) have promise as a regenerative therapy for intervertebral disc (IVD) degeneration, but their maintenance in culture remains challenging. The study hypothesis is that nucleus pulposus (NP) cells can undergo reversion to NC-type cells through CRISPR/dCas9 activation of FoxA2. Serial passaging of cells isolated from NP shows loss of FoxA2, Brachyury (T), and Noto expression. Transient FoxA2 overexpression increased the levels of NC biomarkers, keratin, CD24, and SHH in passaged cells. So FoxA2-expressing cells were generated using CRISPR/dCas9-SAM. Analysis showed the presence of some vacuolated cells, elevated NC marker expression of Fox A2, Noto, Brachyury, and keratin and improved in vitro NP tissue formation (determined by quantifying proteoglycan content). TGFβ3 treatment enhanced tissue formation. Injected FoxA2-expressing cells survived and produced NP matrix molecules in an ex vivo bovine IVD injury model. The findings suggest FoxA2-expressing NC-type cells can be generated which may have potential to advance cell-based therapies for disc degeneration.